Bill Authorizing Medicinal Cannabis Research at VA Gains Bipartisan Traction in House

September 12, 2018 by TWN Staff
Bill Authorizing Medicinal Cannabis Research at VA Gains Bipartisan Traction in House
Rep. Lou Correa (D-Calif.) in an October 2016 file image. He has filed legislation to require the White House and all federal agencies to provide a Spanish-language version of their sites. "It's really just a matter of making government more transparent, more accountable, more effective for more people," Correa said. (Glenn Koenig/Los Angeles Times/TNS)

As medicinal and recreational cannabis laws have swept across states, little progress has been made in Congress to reform longstanding laws prohibiting most cannabis research. Beyond the lack of legal clarity for average citizens prescribed cannabis by their doctors, veterans face even steeper hurdles to acquire a federally illicit medicine that studies have shown great potential for therapeutic benefits for pain management, post-traumatic stress disorder (PTSD), and other chronic ailments.

Although these studies have shown promise, the Department of Veterans Affairs has not shared these findings, in part because they have yet to conduct independent studies to gauge cannabis-based treatments. Despite veterans and doctors urging VA-funded studies and acceptance for treatment, the VA maintains that they do not have the authority to pursue these studies.

New legislation in Congress would authorize VA cannabis research — and it is gaining traction in the House of Representatives.

H.R. 5520, the VA Medicinal Cannabis Research Act of 2018 introduced by Rep. Lou Correa (D-CA) and Rep. Tim Walz (D-MN), ranking member on the House Committee on Veterans Affairs, would specifically authorize the VA to conduct and support research on the efficacy and safety of cannabis for veterans enrolled in the VA health care system diagnosed with conditions such as chronic pain or PTSD.

While data is limited, the American Legion, a congressionally-chartered Veteran Service Organization, conducted a survey in October 2017 on a portion of its approximately 2.2 million veteran members and found that 92% of all respondents support medical research and 82% of all respondents support legalizing medicinal cannabis. The survey also found that “22% of veterans are currently using cannabis to treat a medical condition.”

As many veterans are already using cannabis for medicinal purposes without advisement from their doctor or care provider, it is important that clinicians are able to fully advise veterans on the impacts, harms, and benefits of cannabis use.

Rep. Correa, one of the authors for the bill said, “It is imperative to the health and safety of our veterans that we find alternative treatments for chronic pain and service-related injuries. Throughout my district, I meet veterans who depend on cannabis to manage their pain. Numerous veterans attest to the treatment benefits of medical cannabis. It’s time the VA did a formal study.”

And as the opioid crisis reaches epidemic proportions across the country, and especially for many veterans battling PTSD and chronic pain following overseas tours, cannabis has become popular for self-medication without doctor supervision.

Rep. Correa continued, “Rather than risk becoming dependent on opioids, these veterans find relief in medical cannabis. Opioid prescriptions for veterans have increased by 270 percent since 2003, resulting in 68,000 veterans developing an opioid addiction and a two-fold increase in accidental opioid overdose deaths. This is unacceptable.”

With 55 cosponsors, including 10 Republicans , this message found an audience on the House Committee on Veterans Affairs. In May, the Veterans Affairs Committee passed the bill out of committee. And Judiciary Chairman Bob Goodlatte, a conservative Republican from Virginia, has promised to bring the bill before his committee this year, according to Rolling Stone’s Matt Laslo.

H.R. 5520 still has some hurdles in its path, but with bipartisan support and members engaging in good faith dialogue on behalf of the health and safety of veterans, this bill could be the catalyst to break the longstanding logjam facing cannabis research at the federal level.

Cosponsors of H.R. 5520 include:

Rep. Correa, J. Luis [D-CA-46]*

Rep. Roe, David P. [R-TN-1]*

Rep. Takano, Mark [D-CA-41]

Rep. Brownley, Julia [D-CA-26]

Rep. Coffman, Mike [R-CO-6]

Rep. Kuster, Ann M. [D-NH-2]

Rep. Peters, Scott H. [D-CA-52]

Rep. O’Rourke, Beto [D-TX-16]

Rep. Rice, Kathleen M. [D-NY-4]

Rep. Esty, Elizabeth H. [D-CT-5]

Rep. Blumenauer, Earl [D-OR-3]

Rep. Gaetz, Matt [R-FL-1]

Rep. Clay, Wm. Lacy [D-MO-1]

Rep. Jones, Walter B., Jr. [R-NC-3]

Rep. Rohrabacher, Dana [R-CA-48]

Rep. Johnson, Eddie Bernice [D-TX-30]

Rep. Cohen, Steve [D-TN-9]

Rep. Young, Don [R-AK-At Large]

Rep. Raskin, Jamie [D-MD-8]

Rep. McCollum, Betty [D-MN-4]

Rep. Kihuen, Ruben J. [D-NV-4]

Rep. Pocan, Mark [D-WI-2]

Rep. Smith, Adam [D-WA-9]

Rep. Rosen, Jacky [D-NV-3]

Rep. Panetta, Jimmy [D-CA-20]

Rep. Polis, Jared [D-CO-2]

Rep. Vargas, Juan [D-CA-51]

Rep. Pingree, Chellie [D-ME-1]

Rep. Titus, Dina [D-NV-1]

Rep. Crist, Charlie [D-FL-13]

Rep. Joyce, David P. [R-OH-14]

Rep. Lee, Barbara [D-CA-13]

Rep. Grijalva, Raul M. [D-AZ-3]

Rep. Heck, Denny [D-WA-10]

Rep. DeFazio, Peter A. [D-OR-4]

Rep. Shea-Porter, Carol [D-NH-1]

Rep. Yarmuth, John A. [D-KY-3]

Rep. Swalwell, Eric [D-CA-15]

Rep. DeGette, Diana [D-CO-1]

Rep. Rooney, Thomas J. [R-FL-17]

Rep. Rush, Bobby L. [D-IL-1]

Rep. Schakowsky, Janice D. [D-IL-9]

Rep. Curbelo, Carlos [R-FL-26]

Rep. Norton, Eleanor Holmes [D-DC-At Large]

Rep. Costello, Ryan A. [R-PA-6]

Rep. Perlmutter, Ed [D-CO-7]

Rep. Khanna, Ro [D-CA-17]

Rep. Moulton, Seth [D-MA-6]

Rep. Lujan Grisham, Michelle [D-NM-1]

Rep. Boyle, Brendan F. [D-PA-13]

Rep. Soto, Darren [D-FL-9]

Rep. Rutherford, John H. [R-FL-4]

Rep. Lamb, Conor [D-PA-18]

Rep. Carbajal, Salud O. [D-CA-24]

Rep. Quigley, Mike [D-IL-5]

 

A+
a-

In The News

Health

Voting

Health

May 1, 2024
by Dan McCue
Bipartisan Vote Spells End to Arizona’s Archaic Abortion Law

PHOENIX — Arizona lawmakers voted to repeal the state’s controversial, Civil War-era ban on abortion on Wednesday with two Republicans... Read More

PHOENIX — Arizona lawmakers voted to repeal the state’s controversial, Civil War-era ban on abortion on Wednesday with two Republicans joining with Democrats to ensure the measure passed. The vote in the Republican-controlled Arizona state Senate was 16-14, with every Democrat in the chamber and Republicans... Read More

By Tweaking the IRA, This Legislation Could Save Lives

The impact of the Inflation Reduction Act on the price of medicine is starting to play out. Measures to cap... Read More

The impact of the Inflation Reduction Act on the price of medicine is starting to play out. Measures to cap the price of insulin at $35 a month for Medicare enrollees took effect on Jan. 1. In 2025, the IRA will cap annual out-of-pocket prescription drug... Read More

May 1, 2024
by TWN Staff
CDC Issues Warning of E. coli Outbreak Tied to Walnuts

WASHINGTON — The Centers for Disease Control and Prevention on Tuesday issued a warning to consumers of a risk of... Read More

WASHINGTON — The Centers for Disease Control and Prevention on Tuesday issued a warning to consumers of a risk of contracting E. coli from Gibson Farms organic walnuts sold in bulk at natural food stores. Most of the cases have occurred in Washington and California. Gibson... Read More

Some North Carolina Abortion Pill Restrictions Are Unlawful, Federal Judge Says

RALEIGH, N.C. (AP) — Some of North Carolina government's restrictions on dispensing abortion pills, such as requiring that doctors to... Read More

RALEIGH, N.C. (AP) — Some of North Carolina government's restrictions on dispensing abortion pills, such as requiring that doctors to prescribe and provide the drug to the patient in person, are unlawful because they frustrate the goal of Congress to use federal regulators to ensure the... Read More

May 1, 2024
by Dan McCue
Feds Extend Deadline for Comment on Corporate Greed in Health Care

WASHINGTON — Officials overseeing a recently launched cross-government inquiry on the impact of corporate greed on the nation’s health care... Read More

WASHINGTON — Officials overseeing a recently launched cross-government inquiry on the impact of corporate greed on the nation’s health care system are already extending the deadline for public comment. The comment period was originally set to end on May 6. It has now been extended to... Read More

May 1, 2024
by Dan McCue
Clinical Trial Links Frequent Anger to Increased Risk of Heart Disease

WASHINGTON — Recurring bouts of anger may increase a person’s risk of developing heart disease, according to a study published... Read More

WASHINGTON — Recurring bouts of anger may increase a person’s risk of developing heart disease, according to a study published Wednesday in the Journal of the American Heart Association. The study, which was funded by the National Heart, Lung, and Blood Institute, is the first to... Read More

News From The Well
scroll top